- Drugs
- Thursday, 19 Sep 2019
Aphria Inc Launches Plant Positivity Social Impact Platform with Evergreen
Aphria Inc. announced the launch of its new social impact platform, Plant Positivity. The company partnered with not-for-profit Evergreen which will create six new garden spaces at Evergreen Brick Works.
Aphria, Inc. is engaged in the production and supply of medical cannabis. It operates through three reportable segments including cannabis operations, distribution operations, and business under development. The Cannabis Operations segment produces, distributes, and sells both medical and adult-use cannabis. The Distribution Operations segment are carried out through its wholly owned subsidiaries ABP, FL Group, and CC Pharma. The Distribution under Development segment includes operations in which the firm has not received final licensing or has not commenced commercial sales from operations. The company offers medical cannabis of various strains, including Kusawa, Tamaracouta, Panache, Churchill and Iroquois. The Company is also engaged in the research and development, and commercial production of cannabis oil. The company was founded by Cole Cacciavillani and John Cervini on June 22, 2011 and is headquartered in Leamington, Canada. Aphria’s subsidiaries include Pure Natures Wellness Inc. that are engaged in the production and distribution of medical marijuana, and Cannway Pharmaceuticals Ltd., which specializes in offering support services to veterans and their first responders.
Related Industry Updates
Ionis Pharmaceuticals to present at upcoming virtual investor conferences
Jun 05, 2020
North America Antibiotics Market Growth and Trends to 2020-2027 With Top Companies Like Johnson & Johnson Services, Inc, Bristol-Myers Squibb Company, Eli Lilly and Company., Abbott, Pfizer Inc
Dec 09, 2020
Clinical Trials Market is expected to reach US$ 76,023.44 million by 2028
Jul 04, 2023
Novartis scraps sale of assets including COVID-19 hopeful to Indis's Aurobindo Pharma
Apr 02, 2020
Vitamin K2 Market is expected to reach US$ 11,60,779.02 Thousands by 2030
Oct 11, 2023
Datroway (datopotamab deruxtecan) Earns FDA Priority Review
Feb 17, 2026
Herbal Medicine plays a significant role in Healing the Nervous System
Apr 03, 2020